4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001104659-16-163804
Director bought 161,000 shares at $14.00 ($2,254,000)
- Director acquired 6,508,699 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Bolzon Bradley J PhD · Director
Table I: Non-derivative
18 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-10-24 | Conversion : show line 1 in the form | +437,247 | 676,895 | I | ||
| 2016-10-24 | Conversion : show line 2 in the form | +3,100,477 | 3,777,372 | I | ||
| 2016-10-24 | Conversion : show line 3 in the form | +231,077 | 4,008,449 | I | ||
| 2016-10-24 | Purchase : show line 4 in the form | +95,596 | $14.00 | $1,338,344 | 4,104,045 | I |
| 2016-10-24 | Conversion : show line 5 in the form | +2,754 | 2,754 | I | ||
| 2016-10-24 | Conversion : show line 6 in the form | +19,524 | 22,278 | I | ||
| 2016-10-24 | Conversion : show line 7 in the form | +1,454 | 23,732 | I | ||
| 2016-10-24 | Purchase : show line 8 in the form | +602 | $14.00 | $8,428 | 24,334 | I |
| Open-market purchases · 161,000 sh · avg $14.00 · $2,254,000 | ||||||
Table II: Derivative
15 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-10-18 | Grant or award : show line 19 in the form Stock Option (Right to Buy) | +30,000 | $14.00 | 2026-10-18 | 30,000 | 60,000 | I |
| 2016-10-24 | Conversion : show line 20 in the form Series A-1 Preferred Shares | −437,247 | 437,247 | 0 | I | ||
| 2016-10-24 | Conversion : show line 21 in the form Series A-1 Preferred Shares | −2,754 | 2,754 | 0 | I | ||
| 2016-10-24 | Conversion : show line 22 in the form Series A-2 Preferred Shares | −3,100,477 | 3,100,477 | 0 | I | ||
| 2016-10-24 | Conversion : show line 23 in the form Series A-2 Preferred Shares | −19,524 | 19,524 | 0 | I | ||
| 2016-10-24 | Conversion : show line 24 in the form Series A-3 Preferred Shares | −2,210,417 | 2,210,417 | 0 | I | ||
| 2016-10-24 | Conversion : show line 25 in the form Series A-3 Preferred Shares | −66,490 | 66,490 | 0 | I | ||
| 2016-10-24 | Conversion : show line 26 in the form Series A-3 Preferred Shares | −168,224 | 168,224 | 0 | I |
Loading xslF345X03/a4.xml…